SOCM
SR One Capital Management Portfolio holdings
AUM
$461M
This Quarter Return
+7.34%
1 Year Return
+23.25%
3 Year Return
+188.96%
5 Year Return
–
10 Year Return
–
AUM
$232M
AUM Growth
+$232M
(-14%)
Cap. Flow
-$49.1M
Cap. Flow
% of AUM
-21.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$3.85B
| $125M | 53.81% |
3,946,630
-1,553,377
| -28% | -$49.1M |
|
2
Design Therapeutics
DSGN
$315M
| $41.1M | 17.73% |
6,526,476
| – | – |
|
3
Mineralys Therapeutics
MLYS
$1.03B
| $30.6M | 13.19% |
1,794,600
| – | – |
|
4
ARS Pharmaceuticals
SPRY
$1.15B
| $26.9M | 11.59% |
4,012,903
| – | – |
|
|
EFTR
5
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $5.59M | 2.41% |
6,822,114
| – | – |
|
6
Nkarta
NKTX
$151M
| $2.92M | 1.26% |
1,333,333
| – | – |
|